News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
George Simeon
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,000 options to buy
@ $62.59, valued at
$813.7k
|
|
| 06/09/2023 |
4
| George Simeon (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 22,500 options to buy
@ $4.86, valued at
$109.4k
|
|
| 06/02/2023 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 05/15/2023 |
4
| SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 631,932 shares
@ $45, valued at
$28.4M
Sold 370,612 shares
@ $45, valued at
$16.7M
Sold 6,485 shares
@ $46.15, valued at
$299.3k
Sold 3,804 shares
@ $46.15, valued at
$175.6k
|
|
| 12/20/2022 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 500,000 shares
@ $8.2811, valued at
$4.1M
Bought 360,000 shares
@ $8.6336, valued at
$3.1M
Bought 40,000 shares
@ $8.1358, valued at
$325.4k
|
|
| 08/17/2022 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 2,253,660 shares
@ $76, valued at
$171.3M
Disposed/sold 15,000 options to buy
@ $27.06, valued at
$405.9k
Disposed/sold 8,500 options to buy
@ $65.39, valued at
$555.8k
Disposed/sold 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 06/16/2022 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.69, valued at
$205.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Converted 1,550,309 shares
@ $0
Converted 666,651 shares
@ $0
Converted 533,389 shares
@ $0
Converted 649,795 shares
@ $0
Bought 66,667 shares
@ $15, valued at
$1M
Converted 433,196 shares
@ $0
Bought 1,600,000 shares
@ $15, valued at
$24M
Converted 1,550,309 preferred shares
@ $0
Converted 666,651 preferred shares
@ $0
Converted 533,389 preferred shares
@ $0
Converted 649,795 preferred shares
@ $0 |
|
| 02/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/02/2021 |
3
| SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 3 on eFFECTOR Therapeutics, Inc. |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 04/01/2021 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Converted 4,439,839 shares
@ $0
Converted 936,637 shares
@ $0
Bought 250,000 shares
@ $20, valued at
$5M
Converted 7,236,938 preferred shares
@ $0
Converted 1,526,718 preferred shares
@ $0 |
|
| 03/29/2021 |
4
| George Simeon (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $20, valued at
$300k
|
|
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| George Simeon (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 10,700 options to buy
@ $18, valued at
$192.6k
|
|
| 07/09/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2020 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $65.39, valued at
$555.8k
|
|
| 06/15/2020 |
4
| George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $59.7, valued at
$895.5k
|
|
| 06/08/2020 |
4
| George Simeon (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 05/26/2020 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Bought 83,333 shares
@ $60, valued at
$5M
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Bought 177,777 shares
@ $45, valued at
$8M
|
|
| 06/13/2019 |
4
| George Simeon (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $43.52, valued at
$652.8k
|
|
| 06/11/2019 |
4
| George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $31.77, valued at
$325.3k
|
|
| 04/24/2019 |
4
| George Simeon (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Converted 1,120,730 shares
@ $0
Converted 546,820 shares
@ $0
Bought 325,000 shares
@ $18, valued at
$5.9M
Granted 15,000 options to buy
@ $27.06, valued at
$405.9k
Converted 4,314,809 preferred shares
@ $0
Converted 2,105,259 preferred shares
@ $0 |
|
| 04/16/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/10/2019 |
4
| George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 20,475 options to buy
@ $17, valued at
$348.1k
|
|
| 09/20/2018 |
4
| George Simeon (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Converted 1,070,771 shares
@ $0
Converted 312,741 shares
@ $0
Converted 260,617 shares
@ $0
Converted 544,047 shares
@ $0
Converted 167,537 shares
@ $0
Bought 270,000 shares
@ $17, valued at
$4.6M
Converted 1,070,771 preferred shares
@ $0
Converted 312,741 preferred shares
@ $0
Converted 260,617 preferred shares
@ $0
Converted 544,047 options to buy
@ $0
Converted 167,537 preferred shares
@ $0 |
|
|
|
|